PLXP logo

PLx Pharma (PLXP) Stock

Profile

Full Name:

PLx Pharma Inc.

Sector:

Healthcare

Country:

United States

IPO:

13 March 2014

Indexes:

Not included

Description:

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. On April 13, 2023, PLx Pharma Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 12, 2023

Recent annual earnings:

Mar 11, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 20, 2017

Analyst ratings

Recent major analysts updates

15 Aug '22 Oppenheimer
Perform
15 Aug '22 JMP Securities
Market Perform
16 May '22 Raymond James
Outperform
14 Mar '22 Raymond James
Outperform
07 Dec '21 Raymond James
Outperform
21 Sept '21 BWS Financial
Buy
09 Apr '21 Oppenheimer
Outperform
18 May '20 JMP Securities
Market Outperform
14 Mar '19 JMP Securities
Market Outperform
14 Jan '19 Raymond James
Market Perform

Screeners with PLXP included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Why Is PLx Pharma (PLXP) Stock Down 32% Today?
Why Is PLx Pharma (PLXP) Stock Down 32% Today?
Why Is PLx Pharma (PLXP) Stock Down 32% Today?
PLXP
InvestorPlace12 April 2023

PLx Pharma (NASDAQ: PLXP ) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange . An update from PLx Pharma revealed that the Nasdaq is not giving it another 180-day period to regain compliance with listing rules.

Why Is PLx Pharma (PLXP) Stock Down 38% Today?
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
PLXP
InvestorPlace11 April 2023

PLx Pharma (NASDAQ: PLXP ) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. First off, traders will keep in mind that PLXP stock underwent a massive rally on Monday.

FAQ

  • What is the primary business of PLx Pharma?
  • What is the ticker symbol for PLx Pharma?
  • Does PLx Pharma pay dividends?
  • What sector is PLx Pharma in?
  • What industry is PLx Pharma in?
  • What country is PLx Pharma based in?
  • When did PLx Pharma go public?
  • Is PLx Pharma in the S&P 500?
  • Is PLx Pharma in the NASDAQ 100?
  • Is PLx Pharma in the Dow Jones?
  • When was PLx Pharma's last earnings report?
  • When does PLx Pharma report earnings?
  • Should I buy PLx Pharma stock now?

What is the primary business of PLx Pharma?

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. On April 13, 2023, PLx Pharma Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

What is the ticker symbol for PLx Pharma?

The ticker symbol for PLx Pharma is NASDAQ:PLXP

Does PLx Pharma pay dividends?

No, PLx Pharma does not pay dividends

What sector is PLx Pharma in?

PLx Pharma is in the Healthcare sector

What industry is PLx Pharma in?

PLx Pharma is in the Drug Manufacturers - Specialty & Generic industry

What country is PLx Pharma based in?

PLx Pharma is headquartered in United States

When did PLx Pharma go public?

PLx Pharma's initial public offering (IPO) was on 13 March 2014

Is PLx Pharma in the S&P 500?

No, PLx Pharma is not included in the S&P 500 index

Is PLx Pharma in the NASDAQ 100?

No, PLx Pharma is not included in the NASDAQ 100 index

Is PLx Pharma in the Dow Jones?

No, PLx Pharma is not included in the Dow Jones index

When was PLx Pharma's last earnings report?

PLx Pharma's most recent earnings report was on 12 May 2023

When does PLx Pharma report earnings?

The date for PLx Pharma's next earnings report has not been announced yet

Should I buy PLx Pharma stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions